Jeffrey T. Enama

Design and Testing for a Nontagged F1‐V Fusion Protein as Vaccine Antigen against Bubonic and Pneumonic Plague

Bradford S. Powell, Gerard P. Andrews, Jeffrey T. Enama et al. · Biotechnology Progress · 2005 · 92 citations

Veterinary Medicine, Biotechnology, Infectious Diseases +17

VACCINATION WITH F1-V FUSION PROTEIN PROTECTS BLACK-FOOTED FERRETS (MUSTELA NIGRIPES) AGAINST PLAGUE UPON ORAL CHALLENGE WITH YERSINIA PESTIS

Tonie E. Rocke, Susan R. Smith, Paul Marinari et al. · Journal of Wildlife Diseases · 2008 · 32 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +15

Multiple asparagine deamidation of <i>Bacillus anthracis</i> protective antigen causes charge isoforms whose complexity correlates with reduced biological activity

Bradford S. Powell, Jeffrey T. Enama, Wilson J. Ribot et al. · Proteins Structure Function and Bioinformatics · 2007 · 26 citations · Full text

Life Sciences, Biochemistry, Immunology +17

Purification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague

Jeremy L. Goodin, David F. Nellis, Bradford S. Powell et al. · Protein Expression and Purification · 2007 · 26 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +12

Quantitative anti-F1 and anti-V IgG ELISAs as serological correlates of protection against plague in female Swiss Webster mice

S F Little, W.M. Webster, Heike Wilhelm et al. · Vaccine · 2009 · 10 citations

Veterinary Medicine, Immunology, Infectious Diseases +10